Xeris Biopharma Holdings Inc. buy Barclays PLC
Start price
08.12.25
/
50%
€6.01
Target price
08.12.26
-
Performance (%)
0.00%
Price
03.12.25
€5.78
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 08.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Xeris Biopharma Holdings Inc. | 0.00% |
| iShares Core DAX® | 1.659% |
| iShares Nasdaq 100 | 0.381% |
| iShares Nikkei 225® | 2.102% |
| iShares S&P 500 | 0.221% |
Comments by Barclays_PLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for XERS provided by MarketBeat